132 related articles for article (PubMed ID: 16010421)
21. Immunohistochemical localization of bone morphogenetic proteins (BMPs) 2, 4, 6, and 7 during induced heterotopic bone formation.
McCullough KA; Waits CA; Garimella R; Tague SE; Sipe JB; Anderson HC
J Orthop Res; 2007 Apr; 25(4):465-72. PubMed ID: 17262821
[TBL] [Abstract][Full Text] [Related]
22. Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function.
Abdelmagid SM; Barbe MF; Arango-Hisijara I; Owen TA; Popoff SN; Safadi FF
J Cell Physiol; 2007 Jan; 210(1):26-37. PubMed ID: 17034042
[TBL] [Abstract][Full Text] [Related]
23. Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5.
Langenfeld EM; Kong Y; Langenfeld J
Oncogene; 2006 Feb; 25(5):685-92. PubMed ID: 16247476
[TBL] [Abstract][Full Text] [Related]
24. Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model.
Moreau JE; Anderson K; Mauney JR; Nguyen T; Kaplan DL; Rosenblatt M
Cancer Res; 2007 Nov; 67(21):10304-8. PubMed ID: 17974972
[TBL] [Abstract][Full Text] [Related]
25. SMAD expression in the testis: an insight into BMP regulation of spermatogenesis.
Itman C; Loveland KL
Dev Dyn; 2008 Jan; 237(1):97-111. PubMed ID: 18069690
[TBL] [Abstract][Full Text] [Related]
26. Bone morphogenetic proteins 1 to 7 in human breast cancer, expression pattern and clinical/prognostic relevance.
Davies SR; Watkins G; Douglas-Jones A; Mansel RE; Jiang WG
J Exp Ther Oncol; 2008; 7(4):327-38. PubMed ID: 19227012
[TBL] [Abstract][Full Text] [Related]
27. Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells.
Deng H; Makizumi R; Ravikumar TS; Dong H; Yang W; Yang WL
Exp Cell Res; 2007 Mar; 313(5):1033-44. PubMed ID: 17275810
[TBL] [Abstract][Full Text] [Related]
28. Tenascin-W is found in malignant mammary tumors, promotes alpha8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-alpha induced expression in vitro.
Scherberich A; Tucker RP; Degen M; Brown-Luedi M; Andres AC; Chiquet-Ehrismann R
Oncogene; 2005 Feb; 24(9):1525-32. PubMed ID: 15592496
[TBL] [Abstract][Full Text] [Related]
29. Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas.
Wen XZ; Akiyama Y; Baylin SB; Yuasa Y
Oncogene; 2006 Apr; 25(18):2666-73. PubMed ID: 16314833
[TBL] [Abstract][Full Text] [Related]
30. Novel human breast cancer cell lines IBH-4, IBH-6, and IBH-7 growing in nude mice.
Bruzzone A; Vanzulli SI; Soldati R; Giulianelli S; Lanari C; Lüthy IA
J Cell Physiol; 2009 May; 219(2):477-84. PubMed ID: 19194992
[TBL] [Abstract][Full Text] [Related]
31. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Nutr Cancer; 2007; 58(2):162-70. PubMed ID: 17640162
[TBL] [Abstract][Full Text] [Related]
32. Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro.
Jäger M; Fischer J; Dohrn W; Li X; Ayers DC; Czibere A; Prall WC; Lensing-Höhn S; Krauspe R
J Orthop Res; 2008 Nov; 26(11):1440-8. PubMed ID: 18404732
[TBL] [Abstract][Full Text] [Related]
33. The extracellular calcium-sensing receptor reciprocally regulates the secretion of BMP-2 and the BMP antagonist Noggin in colonic myofibroblasts.
Peiris D; Pacheco I; Spencer C; MacLeod RJ
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G753-66. PubMed ID: 17138967
[TBL] [Abstract][Full Text] [Related]
34. Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4.
Ye L; Kynaston H; Jiang WG
Mol Cancer Res; 2008 Oct; 6(10):1594-606. PubMed ID: 18922975
[TBL] [Abstract][Full Text] [Related]
35. Alteration of gene expression in response to bone morphogenetic protein-2 in androgen-dependent human prostate cancer LNCaP cells.
Kumagai T; Tomari K; Shimizu T; Takeda K
Int J Mol Med; 2006 Feb; 17(2):285-91. PubMed ID: 16391828
[TBL] [Abstract][Full Text] [Related]
36. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
37. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
Schubert A; Schulz H; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
[TBL] [Abstract][Full Text] [Related]
38. Bone morphogenetic proteins are expressed by both bone-forming and non-bone-forming lesions.
Khurana JS; Ogino S; Shen T; Parekh H; Scherbel U; DeLong W; Feldman MD; Zhang PJ; Wolfe HJ; Alman BA
Arch Pathol Lab Med; 2004 Nov; 128(11):1267-69. PubMed ID: 15508192
[TBL] [Abstract][Full Text] [Related]
39. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6.
Hennig T; Lorenz H; Thiel A; Goetzke K; Dickhut A; Geiger F; Richter W
J Cell Physiol; 2007 Jun; 211(3):682-91. PubMed ID: 17238135
[TBL] [Abstract][Full Text] [Related]
40. Functional role of bone morphogenetic protein-4 in isolated canine parietal cells.
Nitsche H; Ramamoorthy S; Sareban M; Pausawasdi N; Todisco A
Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G607-14. PubMed ID: 17600042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
